IPOs and Secondaries
IPOs and Secondaries Articles
AdvancePierre Foods intends to offer more than 12 million shares in a secondary offering valued up to around $439 million.
Published:
Last Updated:
Schneider National entered the market relatively quietly in its initial public offering on Thursday.
Published:
Last Updated:
Elevate Credit has decided to price more than 12 million shares at $6.50 in an initial public offering valued up to more than $92 million.
Published:
Last Updated:
Okta intends to price 11 million shares at $15 to $17 apiece in an initial public offering valued up to around $215 million.
Published:
Last Updated:
It is surprising to see a coal company come forward and file to be publicly traded, considering the industry’s recent history.
Published:
Last Updated:
Cadence Bancorp intends to price more than 7 million shares in the range of $19 to $21 apiece in an initial public offering valued up to around $181 million.
Published:
Last Updated:
The road to a pivotal Phase 3 trial usually takes years following an IPO, but Therapix Biosciences may reach that stage in just a few months' time.
Published:
Last Updated:
Everbridge has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its secondary offering.
Published:
Last Updated:
Tocagen expects to price more than 7 million shares in the range of $10 to $12 apiece for an initial public offering valued up to about $100 million.
Published:
Last Updated:
Carvana has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Last Updated:
Cloudera has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Six companies are on the calendar for IPOs next week, including a fintech firm back for a second try as well as a major US trucking company and a Brazilian airline.
Published:
Last Updated:
Ultra-low cost carrier Frontier Airlines has filed preliminary documents for an IPO.
Published:
Last Updated:
Cara Therapeutics has priced more than 4 million shares of common stock at $18 per share in a secondary offering valued up to around $92 million.
Published:
Last Updated:
ELF Beauty has priced its more than 8.34 million shares at $27 apiece in a secondary offering valued up to nearly $259 million.
Published:
Last Updated: